Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04887857 |
Title | A Study to Assess Safety and Tolerability of CC-486 (ONUREG, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML) (OMNIVERSE) |
Acronym | OMNIVERSE |
Recruitment | Completed |
Gender | |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Celgene |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | AUS |